| 28088167
|
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. |
BMC Infect Dis |
2017 |
Mukherjee PK;Esper F;Buchheit K;Arters K;Adkins I;Ghannoum MA;Salata RA |
View
More |
| 29567461
|
PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials. |
Antiviral Res |
2018 |
Malcolm BA;Aerts CA;Dubois KJ;Geurts FJ;Marien K;Rusch S;Van Dijck AH;Verloes R;Vingerhoets J |
View
More |
| 30132922
|
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure. |
J Med Virol |
2019 |
Falsey AR;Walsh EE;Esser MT;Shoemaker K;Yu L;Griffin MP |
View
More |
| 30817023
|
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. |
Clin Transplant |
2019 |
Manuel O;Estabrook M |
View
More |
| 32975011
|
Does bacillus Calmette-Guerin vaccine prevent herpes simplex virus recurrences? A systematic review. |
Rev Med Virol |
2021 |
Pittet LF;Curtis N |
View
More |
| 33864310
|
Effectiveness of supplementation with quercetin-type flavonols for treatment of viral lower respiratory tract infections: Systematic review and meta-analysis of preclinical studies. |
Phytother Res |
2021 |
Brito JCM;Lima WG;Cordeiro LPB;da Cruz Nizer WS |
View
More |
| 35936505
|
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza. |
Mol Gen Microbiol Virol |
2022 |
Ilyicheva TN;Netesov SV;Gureyev VN |
View
More |
| 36139712
|
Antioxidant Effects of Dietary Supplements on Adult COVID-19 Patients: Why Do We Not Also Use Them in Children? |
Antioxidants (Basel) |
2022 |
Notarbartolo V;Montante C;Ferrante G;Giuffre M |
View
More |
| 36589522
|
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections. |
Mol Gen Microbiol Virol |
2022 |
Ilyicheva TN;Netesov SV;Gureyev VN |
View
More |
